Cost-effectiveness analysis of the nonavalent human papillomavirus vaccine for the prevention of cervical cancer in Singapore-Reference-Cited by-同舟云学术

Cost-effectiveness analysis of the nonavalent human papillomavirus vaccine for the prevention of cervical cancer in Singapore

Published:2021-04 Issue:16 Volume:39 Page:2255-2263
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Phua Lee Cheng,Choi Horace C.W.^ORCID,Wu Joseph,Jit Mark,Low Jeffrey^ORCID,Ng Kwong,Pearce Fiona,Hall Cameron,Abdul Aziz Mohamed Ismail

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference41 articles.

1. Singapore Cancer Registry 50th Anniversary Monograph (1968 – 2017). Published November 2019. Available from: https://www.nrdo.gov.sg/publications/cancer.

2. Human papillomavirus 9-valent vaccine for cancer prevention: a systematic review of the available evidence;Signorelli;Epidemiol Infect,2017

3. Health Sciences Authority Singapore. Product insert for Cervarix (human papillomavirus vaccine types 16 and 18) (14 September 2018).

4. Health Sciences Authority Singapore. Product insert for Gardasil (quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine) (September 2019).

5. Health Sciences Authority Singapore. Product insert for Gardasil 9 (human papillomavirus 9-valent vaccine, recombinant) suspension for injection (September 2019).

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrative literature review on human papillomavirus vaccination recommendations in national immunization programs in select areas in the Asia-Pacific region;Human Vaccines & Immunotherapeutics;2024-06-26

2. The cost-effectiveness of school-based interventions for chronic diseases: a systematic review;Cost Effectiveness and Resource Allocation;2024-04-11

3. The Cost-Effectiveness of HPV Vaccination in Asia Pacific Countries: What Lessons Can Indonesia Learn? – A Systematic Review;2024

4. Cost-effectiveness analysis of single-dose or 2-dose of bivalent, quadrivalent, or nonavalent HPV vaccine in a low/middle-income country setting;Journal of Gynecologic Oncology;2024

5. Projected health and economic effects of nonavalent versus bivalent human papillomavirus vaccination in the Netherlands: a data-driven analysis;2023-12-29